Immunotherapy

July 7, 2021
Doctor patient consult in office

Now Enrolling: EA8192 for Upper Urinary Tract Cancer

This phase II/III study is comparing the effect of adding durvalumab to chemotherapy versus chemotherapy alone before surgery
July 7, 2021
Colorectal cancer awareness ribbon

Now Enrolling: EA2201 for Rectal Adenocarcinoma

This phase II study will test the effect of nivolumab plus ipilimumab, with short-course radiation, for the neoadjuvant treatment of patients with low-lying, locally advanced MSI-H/dMMR rectal cancer
May 28, 2021
Doctor patient consult over laptop

Trial Spotlight: Monika Joshi on the INSPIRE Study for Bladder Cancer

The EA8185 phase II trial is the first prospective study exclusively for patients with lymph node positive bladder cancer
March 31, 2021
Doctor patient skin exam

Now Enrolling: EA6194 for Operable Melanoma

This phase II study, led by Dr. Ahmad Tarhini, is testing neoadjuvant treatment with pembrolizumab alone versus pembrolizumab and an investigational drug called CMP-001
February 25, 2021
Older patient throat exam

Now Enrolling: EA3191 for Head and Neck Squamous Cell Carcinoma

This three-arm phase II study, led by Dr. Dan Zandberg, is evaluating pembrolizumab immunotherapy after surgery in patients with recurrent or second primary head and neck cancer with high-risk features
December 14, 2020
Man holding throat

Reopened Trial: Jennifer Eads, MD on Study EA2174 for Esophageal and Gastroesophageal Cancer

EA2174 will evaluate the role of perioperative immunotherapy for patients with esophageal or gastroesophageal junction adenocarcinoma